Shelby Osburn

Dr. Shelby Osburn

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2017 in European Journal of Applied Physiology
Verified
Journal Article
Closed access
PDF file
CHCody Haun
Cody Haun
Mike RobertsMike Roberts
Mike Roberts
MRMatthew A. Romero
Matthew A. Romero
Shelby OsburnShelby Osburn
Shelby Osburn
JHJames C. Healy
James C. Healy
Jeffrey MartinJeffrey Martin
Jeffrey Martin

1 August 2025 in American Journal of Physiology-Endocrinology and Metabolism
Verified
Journal Article
Closed access
BRBradley A. Ruple
Bradley A. Ruple
NCNicholas A. Carlini
Nicholas A. Carlini
JKJason S. Kofoed
Jason S. Kofoed
HRHelya Rostamkhani
Helya Rostamkhani
BHBrady Hanson
Brady Hanson
JTJoel Trinity
Joel Trinity
This study demonstrates that aging alters the transcriptional landscape of PBMCs at rest and in response to acute high-intensity exercise. Older adults exhibited greater transcriptomic responsiveness to exercise, particularly in pathways related to immune signaling and cellular stress. Notably, exercise elicited shared activation of NK cell-mediated processes across age groups, suggesting a conserved immunomodulatory effect. These findings provide molecular insight into how aging and exercise interact to shape immune cell function.

26 February 2026 in Neurology International
Verified
Journal Article
Open access
PDF file
Christopher G BallmannChristopher G Ballmann
Christopher G Ballmann
DSDaphne Schmid
Daphne Schmid
RRRebecca Rogers
Rebecca Rogers
HOHannah Kendrick Oakes
Hannah Kendrick Oakes
Shelby OsburnShelby Osburn
Shelby Osburn
Non-motor symptoms (NMSs) are highly prevalent in Parkinson’s Disease (PD) and contribute significantly to disease severity, progression, and diminished quality of life. NMSs are rooted in both physiological and psychological domains and include emotional dysfunction, autonomic dysregulation, cognitive impairment, pain exacerbation, and neural deficits. While pharmacological approaches are often employed for the alleviation of non-motor symptomology, modest efficacy and adverse side effects may limit their practical utility for individuals with PD, leaving the need for the identification of complementary approaches. Music interventions have emerged as potential adjunctive therapeutic approaches that may positively modulate NMSs in both physiological and psychological domains. Physiologically, music interventions have been shown to alter autonomic activity and pain/sensory perceptions and mediate neurotransmitter release related to arousal, physical effort, and stress. Psychologically, music interventions, both passive and active, have been shown to modulate emotional regulation, motivation, attention, and cognitive performance. Emerging evidence utilizing neuroimaging and behavioral techniques further supports this and suggests music-induced benefits even in the presence of advancing neurodegeneration. Overall, findings from this narrative review suggest music may serve as a potential non-invasive adjunctive therapeutic tool to counteract PD-induced NMSs by adaptively modulating physiological and psychological processes. This narrative review aims to gather current evidence on the physiological and psychological mechanisms underlying the benefits of music and proposes potential therapeutic translation for NMSs in PD. Furthermore, current difficulties, gaps in knowledge, and needs for future research are discussed with the goal of informing directions for clinical translation.

Verified
Journal Article
Open access
PDF file
Christopher G BallmannChristopher G Ballmann
Christopher G Ballmann
DSDaphne Schmid
Daphne Schmid
MPMaggie Pitts
Maggie Pitts
EPEmily Pounds
Emily Pounds
Ashley SizemoreAshley Sizemore
Ashley Sizemore
Shelby OsburnShelby Osburn
Shelby Osburn
Alzheimer’s disease (AD) results in progressive neural degeneration that causes cognitive and non-cognitive symptoms (NCSs). While cognitive symptoms commonly prompt a formal diagnosis, NCSs also contribute significantly to disability, caregiver burden, and overall disease progression. NCSs are rooted in both physiological and psychological consequences of AD, resulting in apathy/motivation loss, emotional dysregulation, anxiety, depression, agitation, and sleep disturbances. Despite progresses in pharmaceutical management of NCSs, variable efficacy, unwanted side effects, and lack of symptom-wide effectiveness often limit therapeutic practicality for people with AD, suggesting a need for the identification of practical adjunctive treatments. Mechanistic evidence of using music interventions as complementary treatment to manage cognitive symptoms in AD has been established, but the potential benefits for NCSs are less clear. Music interventions have the potential to adaptatively alter mechanisms underlying NCSs that span both physiological and psychological domains of symptomology. Physiologically, music has been shown to alter autonomic activity, neurotransmitter release in various brain regions, and mediate hormonal regulation. Psychologically, music interventions have been shown to enhance mechanisms related to motivation, emotional regulation, and resilience to mental stress. Behavioral and neuroimaging evidence further supports this and suggests that the mechanisms of music-induced benefits may aid in counteracting NCSs in people with AD. While the neuromechanistic rationale for music-induced benefits towards NCSs in AD is promising, findings are largely fragmented, leaving therapeutic application difficult. Accordingly, the purpose of this review is to integrate current mechanistic evidence and clinical findings for a rationale and framework for the therapeutic application of music interventions to combat NCSs in AD. Overall, evidence largely supports the use of music as an adjunctive, feasible, and non-invasive therapeutic tool to improve various aspects of NCSs in AD. The translation of mechanistic findings to therapeutic utility are further highlighted. Limitations, challenges, and future directions necessary to fully realize music benefits on NCSs in AD are also discussed with a goal of therapeutic translation.

20 August 2026 in Aging Cell
Verified
Journal Article
Open access
BRBradley A. Ruple
Bradley A. Ruple
NCNicholas A. Carlini
Nicholas A. Carlini
JKJason S. Kofoed
Jason S. Kofoed
HRHelya Rostamkhani
Helya Rostamkhani
BHBrady E. Hanson
Brady E. Hanson
JTJoel Trinity
Joel Trinity
Redox imbalances and mitochondrial dysfunction are key contributors to age‐related declines in skeletal muscle and may contribute to impaired exercise responsiveness. Here, we investigated the influence of aging on skeletal muscle redox at rest and in response to acute exercise, examining how mitochondrial quality and quantity relate to skeletal muscle redox status. Skeletal muscle biopsies were obtained from 12 young (22 ± 4 years) and 10 older adults (66 ± 7 years) before and immediately after 60‐min of high‐intensity knee‐extension exercise. We assessed mitochondrial respiration, mitochondrial DNA (mtDNA) copy number and deletion mutation frequency at baseline, while skeletal muscle redox proteomics was performed on pre‐ and post‐exercise biopsies in a subset of participants. Mitochondrial respiration was preserved with age (max respiration, p = 0.123). However, the older adults had a lower mtDNA copy number ( p = 0.046) and higher mtDNA deletion frequency ( p = 0.001), with widespread remodeling of the skeletal muscle redox proteome, including altered thiol occupancy of proteins involved in metabolism, immune function, and extracellular matrix organization. In response to exercise, young skeletal muscle exhibited predominantly reversible peptide reductions, whereas preferential oxidation of mitochondrial antioxidant proteins, including PRDX3, occurred in older muscle. Both mtDNA deletion frequency and mitochondrial respiration were strongly associated with exercise‐induced redox modifications in mitochondrial proteins. These findings suggest that aging alters both the regulation and resolution of exercise‐induced redox signaling, with mitochondrial genomic instability and respiration shaping redox responsiveness.

1 May 2025 in Physiological Genomics
Verified
Journal Article
Closed access
Shelby OsburnShelby Osburn
Shelby Osburn
MSMeghan E. Smith
Meghan E. Smith
DWDevin Wahl
Devin Wahl
TLThomas J LaRocca
Thomas J LaRocca
Recent studies suggest that the nucleoside reverse transcriptase inhibitor 3TC may improve brain health and cognitive function in old mice, but its effects on other aging tissues have not been comprehensively studied. This is the first study to use a multiomics approach to investigate the effects of 3TC treatment on skeletal muscle of old mice. The results suggest that 3TC reverses age-related transcriptomic and metabolite signatures and is potentially beneficial for mitochondrial function in aged muscle.